BioCentury
ARTICLE | Company News

Cevec, Paragon Bioservices Inc. deal

March 17, 2014 7:00 AM UTC

Cevec said that an evaluation by CRO Paragon showed Cevec's CAP cells were able to produce "very high" titers of respiratory syncytial virus (RSV). Cevec said the RSV produced in the CAP cells showed ...